In summary, the detection of PYCR1, IRS1, Nucleolin lactylation, MADD, HDAC1, and HDAC2 holds potential clinical value in early diagnosis, prognosis assessment, and personalized treatment of liver cancer. The gene discussed is PYCR1; the disease is liver cancer.